Projects proposed in response to this FOA are expected to focus on one of two possible ways to enhance QI methods for prediction and/or measurement of response to therapy:
1. Need for validated QI methods or imaging standards: Development, optimization, and validation of state-of-the-art QI methods that have the potential to be incorporated into future clinical trial settings (single site phase 1 or 2 clinical trials).
2. Validation of QI Methods in Clinical Trials: Emphasis on the need to extend initial software tool development and optimization to analyze performance in the multisite clinical trial (phase 3), where multiple platforms are used for data collection. This may involve evaluation of a range of multimodal imaging approaches, harmonization of image data collection, analysis, display and clinical workflow methods across imaging platforms, or testing their performance across different cancer sites.
Within the scope of this FOA, the important issues to be considered are:
– Clinical Data Collection.
– Importance of Quality Control for QI Methods.
– Optimization of Software Tools for targeted cancer problems.
– Metrology Tools.
– Development and Optimization of QI Methods and Software Tools for phase three trial data sets.
Under this FOA, the NCI will not support:
– Any aspect of the coordination, administration, or functioning of any clinical trial, or correlative studies;
– The development of any imaging hardware components or imaging systems, including hardware for correlative studies;
– The use of prototype imaging platforms/instruments for data collection; and
– The development of new laboratory assays.
1- Declaration of interest: IISPV’s deadline: June 21, 2014 (email@example.com) – NIH Register; create PI account(s); affiliate PI account to IISPV, etc. ull proposal: IISPV’s deadline: Application September 22, 2014
October 05, 2014
Omple el següent formulari per rebre més informació:
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
|cookielawinfo-checkbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checkbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.